| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.32 | 2e-05 |